A common asthma inhaler has been recalled in the UK due to a labelling error that could mislead patients about their dosage.

Fractional exhaled Nitric Oxide (FeNO) is widely used in both primary and secondary care settings across the world. Many ...

The UK's drug watchdog has issued an urgent recall of a widely prescribed asthma inhaler following the discovery of a serious ...

GSK’s follow-up to severe asthma therapy Nucala, depemokimab, clears two phase 3 trials, reducing attacks compared to placebo with six-monthly dosing.

Verona Pharma has blockbuster hopes for its recently approved drug for chronic obstructive pulmonary disorder (COPD), and preliminary sales figures for the drug suggest it is heading in the right ...

New guidelines offer actionable recommendations for diagnosing and managing asthma, making it easier for primary care ...

I had a complete hysterectomy in my late 40s due to endometriosis. I am now 68 and have been on 0.1-mg patches of estradiol ...

Overview of Therapeutic Drug Monitoring MarketThe Global Therapeutic Drug Monitoring Market is valued at USD 2.5 Billion in ...

Breztri Aerosphere is a brand‑name COPD prescription combining an inhaled corticosteroid, a long‑acting beta agonist, and a muscarinic antagonist, sold only ...